Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2026-04-01 @ 9:49 PM
Study NCT ID:
NCT01044459
Status:
COMPLETED
Last Update Posted:
2017-04-20
First Post:
2010-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-11
Start Date Type:
None
Primary Completion Date:
2011-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-04
Completion Date Type:
ACTUAL
First Submit Date:
2010-01-05
First Submit QC Date:
None
Study First Post Date:
2010-01-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-08-14
Results First Submit QC Date:
None
Results First Post Date:
2012-09-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-08-01
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-03-09
Last Update Post Date:
2017-04-20
Last Update Post Date Type:
ACTUAL